Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Auris Medical (EARS)

Auris Medical (EARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Auris Medical CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11 BMU

www.aurismedical.com P: 212-262-6700

Description:

Auris Medical Holding AG is a biopharmaceutical company. It focuses on developing therapies for the treatment of hearing loss and tinnitus. The Company has two projects in advanced clinical development: AM-101 for the treatment of acute inner ear tinnitus and AM-111 for the treatment of acute inner ear hearing loss. Auris Medical Holding AG is headquartered in Zug, Switzerland.

Key Statistics

Overview:

Market Capitalization, $K 34,765
Shares Outstanding, K 11,417
Annual Sales, $ 174 K
Annual Net Income, $ -8,750 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,691 K
60-Month Beta 1.17
% of Institutional Shareholders 6.03%
Float, K 11,417
% Float 100.00%

Growth:

1-Year Return 202.99%
3-Year Return -41.44%
5-Year Return -99.62%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.18%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 06/30/21
Earnings Per Share ttm 0.00
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 05/01/19

EARS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales 96.49
Price/Cash Flow N/A
Price/Book 1.94
Book Value/Share 0.00
Interest Coverage -61.64
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar